Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110218758A reveals enzymatic lutein ester synthesis offering high purity and mild conditions for reliable pharmaceutical intermediate supply chain optimization.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN113603574B reveals a novel silicotungstic catalyst for cyclopentene oxidation offering high yield and recyclability for industrial glutaraldehyde manufacturing.
Patent CN115304506A reveals a green boron-catalyzed transamidation method. Achieve high-purity secondary amides with reduced costs and simplified supply chains for pharmaceutical manufacturing.
Novel strained-ring phosphine catalysts from patent CN108250239B enable efficient intramolecular Wittig reactions with high yields and simplified purification for API synthesis.
Novel Pd-catalyzed method ensures high selectivity and mild conditions for olefin isomerization, offering supply chain stability and cost efficiency for global chemical manufacturing.
Patent CN119569533B reveals a waste-free synthesis route for 1,2,4-trifluorobenzene. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN100540519C reveals a safer PTC-catalyzed route for 3,4-dimethoxyphenylacetaldehyde. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Novel Lewis acid catalyzed route offers mild conditions and high purity for complex heterocyclic pharmaceutical intermediates.
Patent CN115725668B reveals high-purity L-vinylglycine via multi-enzyme cascade. Offers supply chain reliability and cost reduction in agrochemical intermediate manufacturing.
Novel barbituric acid-based carbon bond catalysts offering superior solubility and efficiency for pharmaceutical intermediate manufacturing.
Patent CN110963876A details a novel Pd-132 catalyzed route for 9,10-substituted anthracene, offering >99.99% purity and significant cost reduction in electronic chemical manufacturing.
Patent CN105503767B reveals a novel catalytic method for oxazole ketone compounds. Achieves high yield and purity for reliable pharmaceutical intermediates supply chains.
Patent CN102321054B details a green cerium-catalyzed route to tetrahydrofuran-3-ones, offering high yields, catalyst recycling, and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1993472A details a lipase-catalyzed route for chiral 3-hydroxy acids, offering cost reduction in API manufacturing and superior supply chain reliability.
Patent CN117660389A reveals mutant transaminase for chiral amines. Offers high conversion and purity for pharma and agrochemical manufacturing supply chains.
Novel Lewis acid catalysis method for EGFR inhibitor formula I ensures high purity and scalability. Reduced impurities offer reliable pharma intermediate supplier advantages for global procurement teams.
Patent CN110372566B details a novel asymmetric rearrangement method yielding high-purity oxindoles with quaternary centers, offering significant cost and supply chain advantages.
Patent CN103864637B reveals a mild TfOH-catalyzed route for N-(β-nitroalkyl) amides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Patent CN105358687B reveals surface displayed designer cells for efficient chiral alcohol production offering significant supply chain and cost advantages for pharmaceutical manufacturing.